Handelsbanken Fonder’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-10,716
Closed -$446K 1590
2023
Q2
$446K Hold
10,716
﹤0.01% 1133
2023
Q1
$443K Buy
10,716
+200
+2% +$8.55K ﹤0.01% 1062
2022
Q4
$434K Hold
10,516
﹤0.01% 1036
2022
Q3
$461K Hold
10,516
﹤0.01% 1013
2022
Q2
$517K Hold
10,516
﹤0.01% 1004
2022
Q1
$596K Hold
10,516
﹤0.01% 1079
2021
Q4
$552K Hold
10,516
﹤0.01% 1278
2021
Q3
$629K Hold
10,516
﹤0.01% 1202
2021
Q2
$713K Buy
10,516
+1,800
+21% +$123K ﹤0.01% 1118
2021
Q1
$571K Hold
8,716
﹤0.01% 1128
2020
Q4
$491K Hold
8,716
﹤0.01% 1170
2020
Q3
$423K Hold
8,716
﹤0.01% 1075
2020
Q2
$485K Buy
+8,716
New +$504K ﹤0.01% 978

Other funds holding NUVA

Handelsbanken Fonder's NUVA Position: Q3 2023 in Review

Handelsbanken Fonder sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 10,716 shares — an estimated $446K sold.

Handelsbanken Fonder first reported a position in NUVA in Q2 2020 and held it in 13 quarters. The position peaked at $713K in Q2 2021. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.

  • Handelsbanken Fonder reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
  • Handelsbanken Fonder sold 10,716 NuVasive, Inc. shares in Q3 2023, an estimated $446K.
  • Handelsbanken Fonder first reported a position in NuVasive, Inc. in Q2 2020 and held it in 13 quarters.
  • Handelsbanken Fonder's NuVasive, Inc. position peaked at $713K in Q2 2021.
  • 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.

Based on Handelsbanken Fonder's 13F filing for Q3 2023, filed 19 Oct 2023.